Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisphosphonates for radiation-induced telangiectasia in breast cancer survivors
NL-OMON36371Not yet recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Feb 2011
- Countries
- 1
01
Overview
Open-label, single-arm trial in telangiectasia and cutaneous radiation injury (CRI), sponsored by Netherlands Cancer Institute. Planned start Feb 2011; status: not yet recruiting.
02
Conditions
telangiectasiacutaneous radiation injury (CRI)
Beyond the preview
Go deeper on NL-OMON36371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36371.